Pancreatic Neuroendocrine Tumor (pNET): Survival Benefits and Efficacy of Peptide Receptor Radionuclide Therapy (PRRT) Using Y-90/Lu-177 DOTA-TATE

被引：0

作者：

Prasad, V ^{[1
]}

Hoersch, D. ^{[1
]}

Hommann, M. ^{[1
]}

Zachert, C. ^{[1
]}

Baum, R. P. ^{[1
]}

机构：

[1] Zent Klin Bad Berka, Bad Berka, Germany

来源：

NEUROENDOCRINOLOGY | 2009年 / 90卷 / 01期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：132 / 133

页数：2

共 50 条

[1] Survival benefits and efficacy of peptide receptor radionuclide therapy (PRRT) using Y-90/Lu-177 DOTA-TATE in pancreatic neuroendocrine tumor (pNET)
Prasad, V.
Hoersch, D.
Hommann, M.
Zachert, C.
Baum, R. P.
[J]. JOURNAL OF NUCLEAR MEDICINE, 2009, 50
[2] Lu-177 DOTA-TATE for peptide receptor Radionuclide therapy (PRRT): Organ, tumor, and blood kinetics
Wehrmann, C.
Senftleben, S.
Baum, R. P.
[J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 : S358 - S359
[3] Impact of Peptide Receptor Radionuclide Therapy using Y-90 DOTA-TATE/Lu-177 DOTA-TATE on renal tubular function: Long term follow-up
Prasad, V.
Baum, R. P.
[J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 : S351 - S351
[4] Lu-177 DOTA-TATE for peptide receptor radionuclide therapy (PRRT): organ-, tumor- and blood kinetics
Wehrmann, C.
Senftleben, S.
Baum, R. P.
[J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 : S338 - S339
[5] First comparative dosimetric results after peptide receptor radionuclide therapy (PRRT) using Lu-177 DOTA-NOC and Lu-177 DOTA-TATE
Wehrmann, C.
Senftleben, S.
Baum, R. P.
[J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 : S373 - S373
[6] First comparative dosimetric results after peptide receptor radionuclide therapy (PRRT) using Lu-177 DOTA-NOC and Lu-177 DOTA-TATE
Wehrmann, C.
Senftleben, S.
Baum, R. P.
[J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 : S179 - S179
[7] Impact of Peptide Receptor Radionuclide Therapy Using Y-90 DOTA-TATE/Lu-177 DOTA-TATE on Renal Tubular Function: Long-Term Follow-Up
Prasad, V
Baum, R. P.
[J]. NEUROENDOCRINOLOGY, 2009, 90 (01) : 132 - 132
[8] Dosimetry in peptide receptor Radionuclide therapy (PRRT) using Lu-177 DOTA-TATE: Intra- and interpatient variability
Wehrmann, C.
Senftleben, S.
Baum, R. P.
[J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 : S178 - S179
[9] Impact of two cycles of peptide receptor radionuclide therapy (PRRT) on renal function as determined by repeated Tc-99m DTPA/GFR measurements: comparison between Y-90 DOTA-TATE and Lu-177 DOTA-TATE
Prasad, V.
Baum, R. P.
[J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 : S325 - S325
[10] Preliminary Results of Lu-177 DOTA-TATE Therapy in Patients with Neuroendocrine Tumor
Hekimsoy, T.
Isgoren, S.
Gorur, G. Daglioz
Demir, H.
[J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S596 - S596

← 1 2 3 4 5 →